Literature DB >> 9420328

Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor.

C Hidai1, T Zupancic, K Penta, A Mikhail, M Kawana, E E Quertermous, Y Aoka, M Fukagawa, Y Matsui, D Platika, R Auerbach, B L Hogan, R Snodgrass, T Quertermous.   

Abstract

We have taken advantage of an enhancer trap event in a line of transgenic mice to identify a unique developmentally regulated endothelial cell locus (Del1). The protein encoded in this locus contains three EGF-like repeats homologous to those in Notch and related proteins, including an EGF-like repeat that contains an RGD motif, and two discoidin I-like domains. Del1 is shown to be a matrix protein and to promote adhesion of endothelial cells through interaction with the alphavbeta3 integrin receptor. Embryonic endothelial-like yolk sac cells expressing recombinant Del1 protein, or grown on an extracellular matrix containing Del1 protein, are inhibited from forming vascular-like structures. Expression of Del1 protein in the chick chorioallantoic membrane leads to loss of vascular integrity and promotes vessel remodeling. Del1 is thus a new ligand for the alphavbeta3 integrin receptor and may function to regulate vascular morphogenesis or remodeling in embryonic development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420328      PMCID: PMC529342          DOI: 10.1101/gad.12.1.21

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  50 in total

1.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

Authors:  P C Maisonpierre; C Suri; P F Jones; S Bartunkova; S J Wiegand; C Radziejewski; D Compton; J McClain; T H Aldrich; N Papadopoulos; T J Daly; S Davis; T N Sato; G D Yancopoulos
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

2.  Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation.

Authors:  I Flamme; M von Reutern; H C Drexler; S Syed-Ali; W Risau
Journal:  Dev Biol       Date:  1995-10       Impact factor: 3.582

Review 3.  Notch signaling.

Authors:  S Artavanis-Tsakonas; K Matsuno; M E Fortini
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

4.  Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.

Authors:  S Davis; T H Aldrich; P F Jones; A Acheson; D L Compton; V Jain; T E Ryan; J Bruno; C Radziejewski; P C Maisonpierre; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

5.  Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

Authors:  P C Brooks; S Strömblad; L C Sanders; T L von Schalscha; R T Aimes; W G Stetler-Stevenson; J P Quigley; D A Cheresh
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

6.  Angiostatin induces and sustains dormancy of human primary tumors in mice.

Authors:  M S O'Reilly; L Holmgren; C Chen; J Folkman
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

7.  Directed endothelial differentiation of cultured embryonic yolk sac cells in vivo provides a novel cell-based system for gene therapy.

Authors:  Y Wei; T Quertermous; T E Wagner
Journal:  Stem Cells       Date:  1995-09       Impact factor: 6.277

8.  Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer.

Authors:  F Alves; W Vogel; K Mossie; B Millauer; H Höfler; A Ullrich
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

9.  Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.

Authors:  D J Dumont; G Gradwohl; G H Fong; M C Puri; M Gertsenstein; A Auerbach; M L Breitman
Journal:  Genes Dev       Date:  1994-08-15       Impact factor: 11.361

10.  An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization.

Authors:  C J Drake; D A Cheresh; C D Little
Journal:  J Cell Sci       Date:  1995-07       Impact factor: 5.285

View more
  71 in total

1.  Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta.

Authors:  J Lu; S Y Chen; H H Chua; Y S Liu; Y T Huang; Y Chang; J Y Chen; T S Sheen; C H Tsai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients.

Authors:  Jian-Cong Sun; Xiao-Ting Liang; Ke Pan; Hui Wang; Jing-Jing Zhao; Jian-Jun Li; Hai-Qing Ma; Yi-Bing Chen; Jian-Chuan Xia
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

3.  DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates.

Authors:  Jieun Shin; Tomoki Maekawa; Toshiharu Abe; Evlambia Hajishengallis; Kavita Hosur; Kalyani Pyaram; Ioannis Mitroulis; Triantafyllos Chavakis; George Hajishengallis
Journal:  Sci Transl Med       Date:  2015-09-30       Impact factor: 17.956

4.  Structure and function of a vimentin-associated matrix adhesion in endothelial cells.

Authors:  M Gonzales; B Weksler; D Tsuruta; R D Goldman; K J Yoon; S B Hopkinson; F W Flitney; J C Jones
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

5.  FOG-2 attenuates endothelial-to-mesenchymal transformation in the endocardial cushions of the developing heart.

Authors:  Alleda E Flagg; Judy U Earley; Eric C Svensson
Journal:  Dev Biol       Date:  2006-12-21       Impact factor: 3.582

6.  An epidermal growth factor-like repeat of Del1 protein increases the efficiency of gene transfer in vitro.

Authors:  Hisataka Kitano; Chiaki Hidai; Masatoshi Kawana; Shinichiro Kokubun
Journal:  Mol Biotechnol       Date:  2008-03-06       Impact factor: 2.695

7.  The secreted protein DEL-1 activates a β3 integrin-FAK-ERK1/2-RUNX2 pathway and promotes osteogenic differentiation and bone regeneration.

Authors:  Da-Yo Yuh; Tomoki Maekawa; Xiaofei Li; Tetsuhiro Kajikawa; Khalil Bdeir; Triantafyllos Chavakis; George Hajishengallis
Journal:  J Biol Chem       Date:  2020-04-12       Impact factor: 5.157

8.  Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo.

Authors:  Hisataka Kitano; Yoh Masaoka; Atsushi Mamiya; Yusuke Fujiwara; Toshio Miki; Chiaki Hidai
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

9.  Coronary heart disease alters intercellular communication by modifying microparticle-mediated microRNA transport.

Authors:  Nnenna A Finn; Danny Eapen; Pankaj Manocha; Hatem Al Kassem; Bernard Lassegue; Nima Ghasemzadeh; Arshed Quyyumi; Charles D Searles
Journal:  FEBS Lett       Date:  2013-09-13       Impact factor: 4.124

10.  Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1.

Authors:  Jingping Zhong; Brian Eliceiri; Dwayne Stupack; Kalyani Penta; Gordon Sakamoto; Thomas Quertermous; Mike Coleman; Nancy Boudreau; Judith A Varner
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.